Liver Cancer Community Education

LIVE-R Life: Liver Cancer Education

This study proposes to bridge the gap between evidence and action and combat rising liver cancer rates attributed to Hepatitis B and C infection in Philadelphia by identifying neighborhoods with higher than expected rates of liver cancer and related risk factors and administering an educational intervention about liver cancer and neighborhood health in those communities, working with existing community partners at Fox Chase Cancer Center.

Study Overview

• Status: Completed
• Conditions: Liver Cancer
• Intervention / Treatment: Behavioral: LIVE-R Life Education

• Study Type: Interventional
• Enrollment (Actual): 67
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Shannon M Lynch, PhD; Phone Number: 215-728-5377; Email: shannon.lynch@fccc.edu

Study Locations

• United States
  • Pennsylvania
    • Philadelphia, Pennsylvania, United States, 19111
      • Fox Chase Cancer Center

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Speaks/reads English
• Lives in Philadelphia or receives healthcare at a community partner site in Philadelphia

Exclusion Criteria:

• None

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: Liver Cancer Education

Behavioral: LIVE-R Life Education; A health educator will present participants with a 30-minute PowerPoint presentation containing educational information about liver cancer risk, screening, prevention, symptoms, and treatments, as well as introduce the concept of neighborhood health (e.g., rates of liver cancer and related risk factors in a census tract and how that might influence individual cancer risk).

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in mean liver cancer knowledge	Liver cancer knowledge will be measured through four true/false items. Responses will be summed for a total liver cancer knowledge score. A positive change in mean knowledge score indicates liver cancer knowledge increased from baseline to post-intervention.	Baseline, 30 minutes
Change in general interest in learning about neighborhood health	General interest in learning about neighborhood health will be measured through a single item asking, on a scale from strongly agree to strongly disagree, whether the participant would like to learn about liver cancer in their own neighborhood. A positive change in mean score indicates that interest increased from baseline to post-intervention.	Baseline, 30 minutes
Change in interest in learning about neighborhood health from a healthcare provider	Interest in learning about neighborhood health from a healthcare provider will be measured through a single item asking, on a scale from strongly agree to strongly disagree, whether the participant would like to learn about liver cancer in their own neighborhood from their doctor. A positive change in mean score indicates that interest increased from baseline to post-intervention.	Baseline, 30 minutes
Change in interest in learning about neighborhood health from other sources	Interest in learning about neighborhood health from other sources will be measured through a single item asking, on a scale from strongly agree to strongly disagree, whether the participant would like to learn about liver cancer in their own neighborhood from non-medical sources (e.g., website or brochure). A positive change in mean score indicates that interest increased from baseline to post-intervention.	Baseline, 30 minutes
Change in interest in discussing high liver cancer risk with a healthcare provider	Interest in discussing high liver cancer risk with a healthcare provider will be measured through a single item asking, on a scale from strongly agree to strongly disagree, whether the participant would be likely to discuss their liver cancer risk with a doctor if they learned they lived in a high-risk area. A positive change in mean score indicates that interest increased from baseline to post-intervention.	Baseline, 30 minutes
Change in outcome expectancies for learning about neighborhood health - patient behavior	Patient outcome expectancies for learning about neighborhood health will be measured through a single item asking, on a scale from 0 (not at all) to 10 (very much), whether learning about neighborhood health will help the participant make health decisions. A positive change in mean score indicates that outcome expectancies increased from baseline to post-intervention.	Baseline, 30 minutes
Change in outcome expectancies for learning about neighborhood health - provider behavior	Provider outcome expectancies for learning about neighborhood health will be measured through a single item asking, on a scale from 0 (not at all) to 10 (very much), whether learning about neighborhood health will help the participant's healthcare provider make health decisions for them. A positive change in mean score indicates that outcome expectancies increased from baseline to post-intervention.	Baseline, 30 minutes
Change in intentions about communicating with healthcare provider - neighborhood prevalence of liver cancer	intentions about communicating with healthcare provider about neighborhood liver cancer will be measured through a single item asking, on a scale from very likely to not at all likely, how likely the participant is to discuss liver cancer in their neighborhood with their healthcare provider over the next 12 months. A positive change in mean score indicates that intentions increased from baseline to post-intervention.	Baseline, 30 minutes
Change in intentions about communicating with healthcare provider - liver cancer screening	intentions about communicating with healthcare provider about liver cancer screening will be measured through a single item asking, on a scale from very likely to not at all likely, how likely the participant is to discuss liver cancer screening with their healthcare provider over the next 12 months. A positive change in mean score indicates that intentions increased from baseline to post-intervention.	Baseline, 30 minutes
Change in intentions about communicating with healthcare provider - liver cancer risk	intentions about communicating with healthcare provider about liver cancer risk will be measured through a single item asking, on a scale from very likely to not at all likely, how likely the participant is to discuss their personal risk factors for liver cancer with their healthcare provider over the next 12 months. A positive change in mean score indicates that intentions increased from baseline to post-intervention.	Baseline, 30 minutes

Collaborators and Investigators

• Sponsor: Fox Chase Cancer Center
• Collaborators: Pennsylvania Department of Health

Study record dates

Study Major Dates

• Study Start (Actual): February 11, 2020
• Primary Completion (Actual): April 6, 2023
• Study Completion (Actual): April 6, 2023

Study Registration Dates

• First Submitted: February 13, 2020
• First Submitted That Met QC Criteria: February 13, 2020
• First Posted (Actual): February 17, 2020

Study Record Updates

• Last Update Posted (Estimated): February 22, 2024
• Last Update Submitted That Met QC Criteria: February 21, 2024
• Last Verified: February 1, 2024

More Information

Terms related to this study

• Keywords: prevention; education
• Additional Relevant MeSH Terms: Digestive System Diseases; Neoplasms; Neoplasms by Site; Digestive System Neoplasms; Liver Diseases; Liver Neoplasms
• Other Study ID Numbers: 19-1039

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No